Guide to HeSANDA and Health Data Australia
The Guide to HeSANDA and Health Data Australia is an easy and engaging way to quickly learn how to access and use Health Data Australia, a catalogue of health and medical research developed to make it easier to find existing datasets that can be used for secondary research.
HeSANDA is the...
Keywords: HeSANDA WA
Resource type: activity
Guide to HeSANDA and Health Data Australia
https://courses.retprogram.org/HeSANDA/story.html
https://dresa.org.au/materials/guide-to-hesanda-and-health-data-australia
The Guide to HeSANDA and Health Data Australia is an easy and engaging way to quickly learn how to access and use Health Data Australia, a catalogue of health and medical research developed to make it easier to find existing datasets that can be used for secondary research.
HeSANDA is the Health Studies Australian National Data Asset program led by ARDC, the Australian Research Data Commons, which is funded by the National Critical Research Infrastructure Strategy (NCRIS).
This Guide will explain the process for researchers to find and request access to existing data. It will also show how the Data Provider (the researcher who created the data) always maintains control over their data and decides with whom it is shared.
Julia Fallon-Ferguson
Executive Officer
julia.fallon-ferguson@curtin.edu.au
Clinical Trials Enabling Platform - Western Australia
Please note my working days are Monday to Wednesday
Julia Fallon-Ferguson, Program Manager, WA HeSANDA Node & Executive Officer, Clinical Trials Enabling Platform of WA, Curtin University
Tom Pazoum, Research Education and Training Program, Western Australian Health Translation Network
HeSANDA WA
support
Fluoroquinolone antibiotics and Aortic Aneurysm or Dissection
The main objective of this project was to provide education on the use of data translated to the OMOP common data model. We aimed to showcase how the Atlas interface tool could be used to generate evidence for a highly relevant and significant research question. The clinical question that was...
Keywords: OMOP, Aortic Aneurysm, Fluoroquinolone antibiotics
Fluoroquinolone antibiotics and Aortic Aneurysm or Dissection
https://ohdsi-australia.org/full_tutorial.pdf
https://dresa.org.au/materials/fluoroquinolone-antibiotics-and-aortic-aneurysm-or-dissection
The main objective of this project was to provide education on the use of data translated to the OMOP common data model. We aimed to showcase how the Atlas interface tool could be used to generate evidence for a highly relevant and significant research question. The clinical question that was used to demonstrate the process revolved around investigating the potential association between the use of fluoroquinolones to treat urinary tract infection and the risk of experiencing aortic aneurysm and dissection within 30 days, 3 months, or 12 months of treatment initiation compared to other commonly used antibiotics. The workshop aimed to describe how data are translated to the OMOP CDM, how cohorts can be derived in these data, how to execute a robust analysis, and lastly, how to interpret the results of the study. Specifically, we described the process of translating Australian medicines dispensing data to the OMOP CDM, including the translation of the Australia Pharmaceutical Benefits Schedule data to the international RxNorm standard vocabulary.
The outcome of the project is an on-line training resource that highlights the process of study execution from start to finish. This training package will serve as an exemplar for researchers in Australia to unlock the value of their data that has been translated into the OMOP CDM. The audience for this project was database programmers, researchers, and decision-makers, and all those interested in using data to inform healthcare.
Roger Ward, Nicole Pratt
Roger Ward
Nicole Pratt
Christine Hallinan
OMOP, Aortic Aneurysm, Fluoroquinolone antibiotics